PGEN
Precigen, Inc.NASDAQHealthcare$3.94+0.25%ClosedMarket Cap: $1.18B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
62.71
P/S
129.99
EV/EBITDA
-5.02
DCF Value
$-0.30
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
42.1%
Operating Margin
-1141.1%
Net Margin
-2588.2%
ROE
-8396.7%
ROA
-160.0%
ROIC
-91.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.6M | 58.1% | $-21.7M | $-23.5M | $-0.07 | — |
| FY 2025 | $9.7M | 37.1% | $-106.6M | $-250.6M | $-1.41 | — |
| Q3 2025 | $2.9M | 64.6% | $-34.5M | $-146.3M | $-1.10 | — |
| Q2 2025 | $856.0K | -81.7% | $-31.8M | $-26.6M | $-0.09 | — |
| Q1 2025 | $1.3M | 18.0% | $-22.6M | $-54.2M | $-0.18 | — |
| Q4 2024 | $1.2M | 1.8% | $-28.5M | $-19.7M | $-0.07 | — |
| FY 2024 | $3.9M | -8.7% | $-135.0M | $-126.2M | $-0.47 | — |
| Q3 2024 | $953.0K | -5.9% | $-21.3M | $-24.0M | $-0.09 | — |
| Q2 2024 | $717.0K | -41.4% | $-60.8M | $-58.8M | $-0.23 | — |
| Q1 2024 | $1.1M | -76.1% | $-24.4M | $-23.7M | $-0.10 | — |
| Q4 2023 | $1.2M | -109.0% | $-23.4M | $-33.1M | $-0.13 | — |
| FY 2023 | $6.2M | 1.7% | $-99.8M | $-95.9M | $-0.39 | — |